Literature DB >> 20004266

Mifepristone: ten years later.

Eric A Schaff1.   

Abstract

While pregnant women have sought abortifacients for thousands of years, they had no success at finding one that both worked and did not jeopardize their lives in the process. The discovery of mifepristone, with both anti-glucocorticoid and anti-progesterone properties, has had a profound effect on women's lives while weaving the abortion-related political hazards. Despite the controversies, millions of women around the world have used mifepristone for medical abortion. This review describes how researchers addressed the numerous barriers of a mifepristone abortion (i.e., gestational age limitation, lengthy process, high costs, complex regimen, failures, side effects and complications) and continue to improve upon the limited numbers and types of clinicians offering mifepristone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20004266     DOI: 10.1016/j.contraception.2009.08.004

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Knowledge of medication abortion among adolescent medicine providers.

Authors:  Mandy S Coles; Kevin K Makino; Rachael Phelps
Journal:  J Adolesc Health       Date:  2011-10-14       Impact factor: 5.012

2.  Necrotic epithelial cells in proximal renal tubules of 2nd trimester fetuses: is this "acute tubular necrosis"?

Authors:  Luiz Cesar Peres; Chitra Sethuraman; Mudher Al-Adnani; Marta Cecilia Cohen
Journal:  Int J Clin Exp Pathol       Date:  2012-04-16

3.  Endometriosis: alternative methods of medical treatment.

Authors:  Leticia Muñoz-Hernando; Jose L Muñoz-Gonzalez; Laura Marqueta-Marques; Carmen Alvarez-Conejo; Álvaro Tejerizo-García; Gregorio Lopez-Gonzalez; Emilia Villegas-Muñoz; Angel Martin-Jimenez; Jesús S Jiménez-López
Journal:  Int J Womens Health       Date:  2015-06-11

4.  Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol.

Authors:  Li-Ping Song; Shi-Yan Tang; Cui-Lan Li; Lee-Jaden-Gil-Yu-Kang Zhou; Xue-Tang Mo
Journal:  J Obstet Gynaecol Res       Date:  2018-07-05       Impact factor: 1.730

5.  Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity.

Authors:  Aaron DeBono; David R Thomas; Lindsay Lundberg; Chelsea Pinkham; Ying Cao; J Dinny Graham; Christine L Clarke; Kylie M Wagstaff; Sharon Shechter; Kylene Kehn-Hall; David A Jans
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

6.  Pharmacological Abortion in a Pandemic: An Italian Medico-Legal Perspective.

Authors:  Clara Cestonaro; Anna Aprile; Matteo Bolcato; Daniele Rodriguez; Alessandro Feola; Giulio Di Mizio
Journal:  Int J Environ Res Public Health       Date:  2021-11-16       Impact factor: 3.390

7.  Mifepristone (RU-486®) as a Schedule IV Controlled Drug-Implications for a Misleading Drug Policy on Women's Health Care.

Authors:  Yi-Ping Hsieh; Yun-Ju Wang; Ling-Yi Feng; Li-Tzy Wu; Jih-Heng Li
Journal:  Int J Environ Res Public Health       Date:  2022-07-08       Impact factor: 4.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.